vs
Side-by-side financial comparison of Dexcom (DXCM) and LANDSTAR SYSTEM INC (LSTR). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× LANDSTAR SYSTEM INC). Dexcom runs the higher net margin — 21.2% vs 3.4%, a 17.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 1.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -2.2%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...
DXCM vs LSTR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $267.3M | $39.4M |
| Gross Margin | 62.9% | 9.6% |
| Operating Margin | 25.6% | 4.5% |
| Net Margin | 21.2% | 3.4% |
| Revenue YoY | 21.6% | 1.6% |
| Net Profit YoY | 153.6% | 32.3% |
| EPS (diluted) | $0.67 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.2B | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $267.3M | $39.4M | ||
| Q4 25 | $267.3M | $23.9M | ||
| Q3 25 | $283.8M | $19.4M | ||
| Q2 25 | $179.8M | $41.9M | ||
| Q1 25 | $105.4M | $29.8M | ||
| Q4 24 | $151.7M | $46.2M | ||
| Q3 24 | $134.6M | $50.0M | ||
| Q2 24 | $143.5M | $52.6M |
| Q1 26 | 62.9% | 9.6% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 4.5% | ||
| Q4 25 | 25.6% | 2.5% | ||
| Q3 25 | 20.1% | 2.2% | ||
| Q2 25 | 18.4% | 4.6% | ||
| Q1 25 | 12.9% | 3.4% | ||
| Q4 24 | 17.0% | 4.8% | ||
| Q3 24 | 15.3% | 5.2% | ||
| Q2 24 | 15.7% | 5.6% |
| Q1 26 | 21.2% | 3.4% | ||
| Q4 25 | 21.2% | 2.0% | ||
| Q3 25 | 23.5% | 1.6% | ||
| Q2 25 | 15.5% | 3.5% | ||
| Q1 25 | 10.2% | 2.6% | ||
| Q4 24 | 13.6% | 3.8% | ||
| Q3 24 | 13.5% | 4.1% | ||
| Q2 24 | 14.3% | 4.3% |
| Q1 26 | $0.67 | $1.16 | ||
| Q4 25 | $0.67 | $0.70 | ||
| Q3 25 | $0.70 | $0.56 | ||
| Q2 25 | $0.45 | $1.20 | ||
| Q1 25 | $0.27 | $0.85 | ||
| Q4 24 | $0.37 | $1.30 | ||
| Q3 24 | $0.34 | $1.41 | ||
| Q2 24 | $0.35 | $1.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $411.0M |
| Total DebtLower is stronger | — | $26.1M |
| Stockholders' EquityBook value | $2.7B | $799.0M |
| Total Assets | $6.3B | $1.6B |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $411.0M | ||
| Q4 25 | $917.7M | $452.2M | ||
| Q3 25 | $1.8B | $434.4M | ||
| Q2 25 | $1.2B | $426.2M | ||
| Q1 25 | $904.9M | $473.4M | ||
| Q4 24 | $606.1M | $566.6M | ||
| Q3 24 | $621.2M | $531.3M | ||
| Q2 24 | $939.2M | $504.0M |
| Q1 26 | — | $26.1M | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 |
| Q1 26 | $2.7B | $799.0M | ||
| Q4 25 | $2.7B | $795.7M | ||
| Q3 25 | $2.7B | $888.7M | ||
| Q2 25 | $2.6B | $921.8M | ||
| Q1 25 | $2.3B | $930.8M | ||
| Q4 24 | $2.1B | $972.4M | ||
| Q3 24 | $2.0B | $1.0B | ||
| Q2 24 | $2.4B | $1.0B |
| Q1 26 | $6.3B | $1.6B | ||
| Q4 25 | $6.3B | $1.6B | ||
| Q3 25 | $7.5B | $1.7B | ||
| Q2 25 | $7.3B | $1.7B | ||
| Q1 25 | $6.8B | $1.7B | ||
| Q4 24 | $6.5B | $1.8B | ||
| Q3 24 | $6.4B | $1.8B | ||
| Q2 24 | $6.8B | $1.8B |
| Q1 26 | — | 0.03× | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
